FBP1 and hepatocellular carcinoma: HDAC‐mediated suppression of FBP1 is correlated with decreased H3K27ac in the FBP1 enhancer. Treatment of HCC cells with HDAC inhibitors restores FBP1 expression and inhibits HCC cell growth.426